Mandore Pharma Private Limited
About Mandore Pharma Private Limited
Data last updated:
Mandore Pharma Private Limited is a private limited company based in Shamli, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2019PTC113820. Its GSTIN is 09AAMCM4615J1Z4 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mahendri and Sumita Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Kh No. 44/1/2/3 Delhi Sharanpur Road, Shamli, Uttar Pradesh, India – 247776.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.16 Cr, a growth of 140% compared to the previous year. For the same year it recorded a net profit of ₹24.24 Lakh (net margin 5.8%) and EBITDA of ₹33.05 Lakh (EBITDA margin 7.9%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 51% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mandore Pharma Private Limited's registered office is in Shamli, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKh No. 44/1/2/3 Delhi Sharanpur Road, Shamli, Uttar Pradesh, India – 247776
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mandore Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mandore Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mandore Pharma Private Limited, buy the company report.
Financials of Mandore Pharma Private Limited
FY 2024 filings availableMandore Pharma Private Limited reported revenue of ₹4.16 Cr (up 140% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 51% over five years, including 140% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.9% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mandore Pharma Private Limited, buy the company report.
Board of directors of Mandore Pharma Private Limited
Mandore Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendri Also directs: Mandore Clinic Private Limited | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Sumita Singh Also directs: Mandore Edutech Private Limited | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Mandore Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mandore Pharma Private Limitedthis company | ₹4.16 Cr (FY 2025) | ₹24.24 Lakh | 5.8% | 140.0% | Shamli, Uttar Pradesh, India | |
| Phoenix Remedies Private Limited | ₹4.14 Cr (FY 2024) | 9.0% | Ahmedabad, Gujarat, India | |||
| Kmah Lifescience Private Limited | ₹4.14 Cr (FY 2025) | 52432.0% | Ahmedabad, Gujarat, India | |||
| Nadine Healthcare Private Limited | ₹4.14 Cr (FY 2025) | 3.0% | Kanpur, Uttar Pradesh, India | |||
| Vivrthi Labs Private Limited | ₹4.14 Cr (FY 2024) | -6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Mandore Pharma Private Limited, buy the company report.
Auditor
Mandore Pharma Private Limited is audited by HEMANT SHAH AND ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HEMANT SHAH AND ASSOCIATES LLP | FY 2023 | 0120816W |
Shareholding
The shareholding of Mandore Pharma Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Mandore Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mandore Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mandore Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mandore Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAMCM4615J1Z4 | Uttar Pradesh | Active | 25 Apr 2019 |
To see the full GST registrations and return filing status of Mandore Pharma Private Limited, buy the company report.
Recent activity
Mandore Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Mahendri was appointed as Director on 19 Feb 2019.
Frequently asked questions
Mandore Pharma is an active private limited company based in Shamli, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 2019 (7+ years old) and is registered under CIN U24304UP2019PTC113820.
Mandore Pharma has 2 current directors:
- Mahendri - Director
- Sumita Singh - Director
The latest financial statements of Mandore Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Mandore Pharma is 09AAMCM4615J1Z4, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Mandore Pharma is U24304UP2019PTC113820. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mandore Pharma was incorporated on 19 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Mandore Pharma by revenue are Phoenix Remedies Private Limited, Kmah Lifescience Private Limited, Nadine Healthcare Private Limited, Vivrthi Labs Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Mahendri was appointed as Director on 19 Feb 2019. Sumita Singh was appointed as Director on 19 Feb 2019.
The registered office of Mandore Pharma is at Kh No. 44123 Delhi Sharanpur Road, Shamli, Uttar Pradesh, India – 247776.
Mandore Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Mandore Pharma is compliant as of 27 August 2026. The company is actively filing with the Registrar of Companies.